

DocMorris AG (ZRSEF) Q2 2026 Earnings Call Transcript

DocMorris AG (ZRSEF) Q1 2026 Earnings Call Transcript

DocMorris AG (ZRSEF) Q4 2025 Earnings Call Transcript

DocMorris AG (OTCPK:ZRSEF) Q2 2025 Earnings Conference Call August 19, 2025 5:00 AM ET Company Participants Daniel Wüest - CFO & Member of Executive Board Walter Hess - CEO & Member of Executive Board Conference Call Participants Gian-Marco Werro - Zürcher Kantonalbank, Research Division Sebastian Vogel - UBS Investment Bank, Research Division Urs Kunz - Research Partners AG Volker Bosse - Baader-Helvea Equity Research Walter Hess Good morning, everybody, and thank you for joining today's conference call, which will be hosted by Daniel Wüest, our CFO, and me. Let me start by giving you a quick overview of the key highlights from the first half of 2025.

DocMorris AG (OTCPK:ZRSEF) Q4 2024 Earnings Conference Call March 13, 2025 6:00 AM ET Company Participants Walter Hess - Chief Executive Officer Daniel Wüest - Chief Financial Officer Conference Call Participants Olivier Calvet - UBS Jan Koch - Deutsche Bank Yannik Siering - Stifel Urs Kunz - Research Partners Gian Marco Werro - Zurcher KB Michael Heider - Warburg Research Christopher Johnen - HSBC Operator Hello, ladies and gentlemen and welcome to the DocMorris AG 2024 Full Year Results and Outlook 2025. At this time, all participants have been placed on a listen-only mode.

DocMorris AG (OTCPK:ZRSEF) Q2 2024 Earnings Call Transcript August 20, 2024 5:00 AM ET Company Participants Walter Hess - CEO Marcel Ziwica - CFO Conference Call Participants Urs Kunz - Research Partners Jan Koch - Deutsche Bank Christopher Johnen - HSBC Gian Marco Werro - Zurcher KB Olivier Calvet - UBS Yannik Siering - Stifel Operator Hello, ladies and gentlemen, and welcome to the DocMorris AG conference call regarding the half year results 2024. At this time, all participants have been placed on a listen-only mode.

DocMorris AG (ZRSEF) Q4 2023 Earnings Call Transcript

Swiss online drug retailer DocMorris met expectations on Thursday as it released its full-year results for 2023, helped by structural cost savings.
No recent filings indexed.